Accordingly, primary human macrophages expressing a HER2-CAR have been generated and tested in vitro and in vivo in various preclinical xenograft models, demonstrating therapeutic efficacy, through increased phagocytosis of tumor cells and the conversion of bystander M2 macrophages to M1 polarization [138]. Here, ERBB2 is linked to neoplasm.